Jubilant Life Sciences reports marginal fall in Q3 consolidated net profit
Jubilant Life Sciences has reported results for third quarter ended December 31, 2016.
The company has reported 71.47% fall in its net profit at Rs 8.26 crore for the quarter under review as compared to Rs 28.95 crore for the same quarter in the previous year. Total income of the company decreased by 4.82% at Rs 651.22 crore for the quarter under review as compared Rs 684.20 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported marginal fall of 2.63% in its net profit after tax, minority interest and share of profit / (Loss) of associates and Joint Ventures at Rs 119.78 crore for the quarter ended December 31, 2016, as compared to Rs 123.01 crore for the same quarter in the previous year. However, total income of the company increased by 6.65% at Rs 1496.76 crore for the quarter under review as compared Rs 1403.44 crore for the corresponding quarter previous year.
Technical levels of Jubilant Life Science
Support at 700—680 and Resistance at 730—735
Break and sustain below 680 will take it to 670—650 else could touch its resistance level of 730—735.
Further upside rally will see on close above 735
More will update soon!!
